Our results are in line with previous studies demonstrating the general feasibility of MRI-based radiomics prediction of pCR to NAC and furthermore underline the added value of metabolic features, as the combined analysis of morphologic, functional, and metabolic tumor features achieved the best results in the entire cohort as well as in the subgroup with HR+/HER2. This evidence concerns the gene HR and neoplasm.